SurModics Inc (SRDX):企業の財務・戦略的SWOT分析

◆英語タイトル:SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13063
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

SurModics Inc (SRDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies to healthcare industry. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. The company manufactures and distributes surface coatings to the diagnostic and biomedical research markets. SurModics is headquartered in Minnesota, the US.

SurModics Inc Key Recent Developments

Nov 09,2018: Surmodics Reports Fourth Quarter Fiscal 2018 Results and Issues Fiscal 2019 Guidance
Nov 06,2018: 12-Month Data from Surmodics SurVeil Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2018
Nov 06,2018: 12-Month Data from Surmodics SurVeil® Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2018
Aug 06,2018: Surmodics reports third quarter fiscal 2018 results
May 16,2018: Surmodics Announces Leadership Change and Appointment of Interim CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
SurModics Inc – Key Facts 6
SurModics Inc – Key Employees 7
SurModics Inc – Key Employee Biographies 8
SurModics Inc – Major Products and Services 9
SurModics Inc – History 10
SurModics Inc – Company Statement 13
SurModics Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
SurModics Inc – Business Description 16
Business Segment: In Vitro Diagnostics 16
Overview 16
Performance 16
Business Segment: Medical Device 16
Overview 16
Performance 16
Geographical Segment: Domestic 16
Performance 16
Geographical Segment: Foreign 17
Performance 17
R&D Overview 17
SurModics Inc – SWOT Analysis 18
SWOT Analysis – Overview 18
SurModics Inc – Strengths 18
SurModics Inc – Weaknesses 19
SurModics Inc – Opportunities 20
SurModics Inc – Threats 21
SurModics Inc – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
SurModics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 30
SurModics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 31
SurModics Inc, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Nov 09, 2018: Surmodics Reports Fourth Quarter Fiscal 2018 Results and Issues Fiscal 2019 Guidance 33
Aug 06, 2018: Surmodics reports third quarter fiscal 2018 results 34
May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 35
May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 36
May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 37
Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 38
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
SurModics Inc, Key Facts 6
SurModics Inc, Key Employees 7
SurModics Inc, Key Employee Biographies 8
SurModics Inc, Major Products and Services 9
SurModics Inc, History 10
SurModics Inc, Other Locations 14
SurModics Inc, Subsidiaries 14
SurModics Inc, Key Competitors 22
SurModics Inc, Ratios based on current share price 23
SurModics Inc, Annual Ratios 24
SurModics Inc, Annual Ratios (Cont...1) 25
SurModics Inc, Annual Ratios (Cont...2) 26
SurModics Inc, Interim Ratios 28
SurModics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 30
SurModics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019 31
SurModics Inc, Recent Deals Summary 32
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List of Figures
SurModics Inc, Performance Chart (2014 - 2018) 27
SurModics Inc, Ratio Charts 29
SurModics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019 30
SurModics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019 31

★海外企業調査レポート[SurModics Inc (SRDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ultra Petroleum Corp. (UPL)-石油・ガス分野:企業M&A・提携分析
    Summary Ultra Petroleum Corp. (Ultra) is an independent upstream company which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops its long-life natural gas reserves in the Green River Basin of Wyoming, the Pinedale and Jonah fields, and Appalachian Basin …
  • Cincinnati Bell Inc.:企業の戦略・SWOT・財務情報
    Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Bell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Havells India Ltd (HAVELLS)-エネルギー分野:企業M&A・提携分析
    Summary Havells India Limited (Havells) is a fast moving electrical goods (FMEG) company that carries out the design, production and distribution of a range of world class industrial and consumer electrical products. Its products include building circuit protection products, capacitors, cables and w …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析
    Summary Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytica …
  • Plymouth Rock Assurance Corporation:企業の戦略・SWOT・財務情報
    Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Wynn Macau Ltd:戦略・SWOT・企業財務分析
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Casey’s General Stores, Inc. (CASY):企業の財務・戦略的SWOT分析
    Casey's General Stores, Inc. (CASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Harel Insurance Investments and Financial Services Ltd:企業の戦略・SWOT・財務情報
    Harel Insurance Investments and Financial Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Harel Insurance Investments and Financial Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Beautiful Brands International, LLC:企業の戦略・SWOT・財務分析
    Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report Summary Beautiful Brands International, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Relmada Therapeutics Inc (RLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aptinyx Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆